{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:35:20Z","timestamp":1778618120634,"version":"3.51.4"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T00:00:00Z","timestamp":1516752000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS069616"],"award-info":[{"award-number":["NS069616"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS081426"],"award-info":[{"award-number":["NS081426"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS098228"],"award-info":[{"award-number":["NS098228"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2018.00010","type":"journal-article","created":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T04:29:03Z","timestamp":1516768143000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":43,"title":["A Metadata Analysis of Oxidative Stress Etiology in Preclinical Amyotrophic Lateral Sclerosis: Benefits of Antioxidant Therapy"],"prefix":"10.3389","volume":"12","author":[{"given":"Leila","family":"Bond","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamren","family":"Bernhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyank","family":"Madria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Sorrentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailee","family":"Scelsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassie S.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,1,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1038\/nrn1434","article-title":"Oxidative stress in neurodegeneration: cause or consequence?","volume":"10","author":"Andersen","year":"2004","journal-title":"Nat. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1006\/exnr.2001.7633","article-title":"Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice","volume":"168","author":"Andreassen","year":"","journal-title":"Exp. Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1046\/j.1471-4159.2001.00188.x","article-title":"Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation","volume":"77","author":"Andreassen","year":"","journal-title":"J. Neurochem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1006\/exnr.1998.6984","article-title":"Beneficial effects of lysine acetylsalicylate, a soluble salt of aspirin, on motor performance in a transgenic model of amyotrophic lateral sclerosis","volume":"155","author":"Barneoud","year":"1999","journal-title":"Exp. Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.nbd.2006.06.017","article-title":"Induction of multiple heat shock proteins and neuroprotection in a primary culture model of familial amyotrophic lateral sclerosis","volume":"24","author":"Batulan","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/17482968.2010.502940","article-title":"The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials","volume":"12","author":"Beghi","year":"2011","journal-title":"Amyotroph. Lateral Scler."},{"key":"B7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11010-017-2991-3","article-title":"Carnosine modulates nitric oxide in stimulated murine RAW 264.7 macrophages","volume":"431","author":"Caruso","year":"2017","journal-title":"Mol. Cell. Biochem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00429-009-0226-4","article-title":"Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice","volume":"214","author":"Chen","year":"2010","journal-title":"Brain Struct. Funct."},{"key":"B9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000433581","article-title":"An assessment of possible neuropathology and clinical relationships in 46 sporadic amyotrophic lateral sclerosis patient autopsies","volume":"15","author":"Coan","year":"2015","journal-title":"Neurodegener. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fncel.2013.00234","article-title":"Differential autophagy power in the spinal cord and muscle of transgenic ALS mice","volume":"7","author":"Crippa","year":"2013","journal-title":"Front. Cell Neurosci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/ana.20552","article-title":"Manganese porphyrin given at symptom onset markedly extends survival of ALS mice","volume":"58","author":"Crow","year":"2005","journal-title":"Ann. Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s12031-010-9467-1","article-title":"The \u201cdying-back\u201d phenomenon of motor neurons in ALS","volume":"43","author":"Dadon-Nachum","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.nrl.2013.06.022","article-title":"Oxidative stress in neurological diseases: cause or effect?","volume":"29","author":"D\u00edaz-Hung","year":"2014","journal-title":"Neurolog\u00eda"},{"key":"B14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1385\/JMN:17:1:89","article-title":"Therapeutic efficacy of EGb761 (Gingko biloba extract) in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"17","author":"Ferrante","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3233\/JAD-142208","article-title":"Systematic review of the relationship between amyloid-beta levels and measures of transgenic mouse cognitive deficit in Alzheimer's disease","volume":"44","author":"Foley","year":"2015","journal-title":"J. Alzheimers. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"13173","DOI":"10.1523\/JNEUROSCI.4057-07.2007","article-title":"Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis","volume":"27","author":"Gifondorwa","year":"2007","journal-title":"J. Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/nan.12148","article-title":"Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones","volume":"40","author":"Highley","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fneur.2016.00047","article-title":"Antecedent disease and amyotrophic lateral sclerosis: what is protecting whom?","volume":"7","author":"Hollinger","year":"2016","journal-title":"Front. Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3233\/JAD-170490","article-title":"Cognitive decline in preclinical alzheimer's disease: amyloid-beta versus tauopathy","volume":"61","author":"Huber","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fncel.2015.00248","article-title":"Seeking homeostasis: temporal trends in respiration, oxidation, and calcium in SOD1 G93A amyotrophic lateral sclerosis","volume":"9","author":"Irvin","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3389\/fncel.2015.00462","article-title":"Type I Vs. Type II cytokine levels as a function of SOD1 G93A mouse amyotrophic lateral sclerosis disease progression","volume":"9","author":"Jeyachandran","year":"2015","journal-title":"Front. Cell Neurosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1111\/j.1471-4159.2008.05317.x","article-title":"Proteasomes remain intact, but show early focal alteration in their composition in a mouse model of amyotrophic lateral sclerosis","volume":"105","author":"Kabashi","year":"2008","journal-title":"J. Neurochem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1471-4159.2008.05595.x","article-title":"Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1 mouse model of ALS","volume":"107","author":"Kalmar","year":"2008","journal-title":"J. Neurochem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3233\/JAD-2008-15314","article-title":"Antioxidants in central nervous system diseases: preclinical promise and translational challenges","volume":"15","author":"Kamat","year":"2008","journal-title":"J. Alzheimer's Dis. JAD"},{"key":"B25","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000090364","article-title":"Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis","volume":"2","author":"Kiaei","year":"2005","journal-title":"Neurodegener. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/21678421.2015.1047455","article-title":"State of the field: an informatics-based systematic review of the SOD1-G93A amyotrophic lateral sclerosis transgenic mouse model","volume":"17","author":"Kim","year":"2016","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"B28","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1046\/j.1471-4159.2003.02160.x","article-title":"Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"88","author":"Klivenyi","year":"2004","journal-title":"J. Neurochem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1755-5949.2012.00358.x","article-title":"The importance of preclinical trial timing - a potential reason for the disconnect between mouse studies and human clinical trials in ALS","volume":"18","author":"Kong","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/146608202760834166","article-title":"Synergistic effects of low level stressors in an oxidative damage model of spinal motor neuron degeneration","volume":"3","author":"Kriscenski-Perry","year":"2002","journal-title":"Amyotroph. Lateral Scler. Other Motor Neuron Disord."},{"key":"B31","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1242\/dmm.020099","article-title":"ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons","volume":"8","author":"Lenzi","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"B32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13024-016-0075-6","article-title":"Directly converted patient-specific induced neurons mirror the neuropathology of FUS with disrupted nuclear localization in amyotrophic lateral sclerosis","volume":"11","author":"Lim","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e69540","DOI":"10.1371\/journal.pone.0069540","article-title":"A mouse model of familial ALS has increased CNS levels of endogenous ubiquinol9\/10 and does not benefit from exogenous administration of ubiquinol10","volume":"8","author":"Lucchetti","year":"2013","journal-title":"PLoS ONE"},{"key":"B34","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/mus.20004","article-title":"Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis","volume":"29","author":"Mahoney","year":"2004","journal-title":"Muscle Nerve"},{"key":"B35","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3109\/21678421.2014.951940","article-title":"NP001 regulation of macrophage activation markers in ALS: a phase I clinical and biomarker study","volume":"15","author":"Miller","year":"2014","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"B36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.brainres.2012.10.012","article-title":"Expression of heat shock transcription factor 1 and its downstream target protein T-cell death associated gene 51 in the spinal cord of a mouse model of amyotrophic lateral sclerosis","volume":"1488","author":"Mimoto","year":"2012","journal-title":"Brain Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.freeradbiomed.2014.02.019","article-title":"Neuroprotective effects of the mitochondria-targeted antioxidant MitoQ in a model of inherited amyotrophic lateral sclerosis","volume":"70","author":"Miquel","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"B38","first-page":"A56","article-title":"Undergraduate biocuration: developing tomorrow's researchers while mining today's data","volume":"14","author":"Mitchell","year":"","journal-title":"J. Undergrad. Neurosci. Educ."},{"key":"B39","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000369812","article-title":"Antecedent disease is less prevalent in amyotrophic lateral sclerosis","volume":"15","author":"Mitchell","year":"","journal-title":"Neurodegener. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1089\/neu.2008.0658","article-title":"Pathology dynamics predict spinal cord injury therapeutic success","volume":"25","author":"Mitchell","year":"2008","journal-title":"J. Neurotrauma"},{"key":"B41","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jtbi.2012.01.019","article-title":"Cargo distributions differentiate pathological axonal transport impairments","volume":"300","author":"Mitchell","year":"","journal-title":"J. Theor. Biol."},{"key":"B42","first-page":"59","article-title":"Dynamic meta-analysis as a therapeutic prediction tool for amyotrophic lateral sclerosis","volume-title":"Amyotrophic Lateral Sclerosis","author":"Mitchell","year":""},{"key":"B43","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/lsm.20732","article-title":"Light therapy and supplementary Riboflavin in the SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis (FALS)","volume":"41","author":"Moges","year":"2009","journal-title":"Lasers Surg. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1590\/S0004-282X2009000400040","article-title":"Amyotrophic lateral sclerosis (ALS): three letters that change the people's life for ever","volume":"67","author":"Oliveira","year":"2009","journal-title":"Arq. Neuropsiquiatr."},{"key":"B45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/17482960801900032","article-title":"A systematic review of antioxidant treatment for amyotrophic lateral sclerosis\/motor neuron disease","volume":"9","author":"Orrell","year":"2008","journal-title":"Amyotroph. Lateral Scler."},{"key":"B46","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.neulet.2006.11.058","article-title":"Pyruvate slows disease progression in a G93A SOD1 mutant transgenic mouse model","volume":"413","author":"Park","year":"2007","journal-title":"Neurosci. Lett."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e103438","DOI":"10.1371\/journal.pone.0103438","article-title":"Mitochondria-targeted catalase reverts the neurotoxicity of hSOD1G(9)(3)A astrocytes without extending the survival of ALS-linked mutant hSOD1 mice","volume":"9","author":"Pehar","year":"2014","journal-title":"PLoS ONE"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/j.1471-4159.2006.04018.x","article-title":"Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis","volume":"98","author":"Petri","year":"","journal-title":"J. Neurochem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.nbd.2005.09.013","article-title":"Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"22","author":"Petri","year":"","journal-title":"Neurobiol. Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3233\/JND-140068","article-title":"Characterization of the contribution of genetic background and gender to disease progression in the sod1 g93a mouse model of amyotrophic lateral sclerosis: a meta-analysis","volume":"2","author":"Pfohl","year":"2015","journal-title":"J. Neuromuscul. Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e68256","DOI":"10.1371\/journal.pone.0068256","article-title":"The effect of SOD1 mutation on cellular bioenergetic profile and viability in response to oxidative stress and influence of mutation-type","volume":"8","author":"Richardson","year":"2013","journal-title":"PLoS ONE"},{"key":"B52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1248\/bpb.32.382","article-title":"The Chinese prescription Wen-Pi-Tang extract delays disease onset in amyotrophic lateral sclerosis model mice while attenuating the activation of glial cells in the spinal cord","volume":"32","author":"Sekiya","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"B54","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nbd.2007.12.002","article-title":"Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression","volume":"30","author":"Sharp","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1124\/mol.106.030676","article-title":"Concurrent administration of Neu2000 and lithium produces marked improvement of motor neuron survival, motor function, and mortality in a mouse model of amyotrophic lateral sclerosis","volume":"71","author":"Shin","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1111\/j.1471-4159.2012.07771.x","article-title":"Concurrent blockade of free radical and microsomal prostaglandin E synthase-1-mediated PGE2 production improves safety and efficacy in a mouse model of amyotrophic lateral sclerosis","volume":"122","author":"Shin","year":"2012","journal-title":"J. Neurochem."},{"key":"B57","doi-asserted-by":"publisher","first-page":"483501","DOI":"10.1155\/2014\/483501","article-title":"Resveratrol ameliorates motor neuron degeneration and improves survival in SOD1(G93A) mouse model of amyotrophic lateral","volume":"2014","author":"Song","year":"2014","journal-title":"Sclerosis"},{"key":"B58","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3109\/17482960903420140","article-title":"Pattern of spread and prognosis in lower limb-onset ALS","volume":"11","author":"Turner","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"key":"B59","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/jnen\/61.11.968","article-title":"Upregulation of HSP27 in a transgenic model of ALS","volume":"61","author":"Vleminckx","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bbrc.2013.07.060","article-title":"Differential effects of mutant SOD1 on protein structure of skeletal muscle and spinal cord of familial amyotrophic lateral sclerosis: role of chaperone network","volume":"438","author":"Wei","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B61","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1600-079X.2006.00377.x","article-title":"Reduced oxidative damage in ALS by high-dose enteral melatonin treatment","volume":"41","author":"Weishaupt","year":"2006","journal-title":"J. Pineal Res."},{"key":"B62","volume-title":"Neurological Disorders: Public Health Challenges.","year":"2006"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e43099","DOI":"10.1371\/journal.pone.0043099","article-title":"Creation of an open-access, mutation-defined fibroblast resource for neurological disease research","volume":"7","author":"Wray","year":"2012","journal-title":"PLoS ONE"},{"key":"B64","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1046\/j.1471-4159.2003.01639.x","article-title":"Iron porphyrin treatment extends survival in a transgenic animal model of amyotrophic lateral sclerosis","volume":"85","author":"Wu","year":"2003","journal-title":"J. Neurochem."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s11064-006-9166-z","article-title":"Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"31","author":"Xu","year":"2006","journal-title":"Neurochem. Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1111\/j.1471-4159.2007.04534.x","article-title":"Heat-shock protein 105 interacts with and suppresses aggregation of mutant Cu\/Zn superoxide dismutase: clues to a possible strategy for treating ALS","volume":"102","author":"Yamashita","year":"2007","journal-title":"J. Neurochem."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnins.2018.00010\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T14:12:24Z","timestamp":1526393544000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnins.2018.00010\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,24]]},"references-count":66,"alternative-id":["10.3389\/fnins.2018.00010"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2018.00010","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,24]]},"article-number":"10"}}